Skip to main content
SpringerLink
Log in

Paclitaxel plus cisplatin favoured in ovarian cancer

final results

  • Newsletter Article
  • Published:
PharmacoEconomics & Outcomes News Weekly

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Paclitaxel plus cisplatin favoured in ovarian cancer. Pharmacoecon. Outcomes News 197, 7 (1999). https://doi.org/10.1007/BF03274814

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03274814

Keywords

Search

Navigation